Dr. Shah Discusses Ongoing Research With CAR T-Cell Therapy

Video

Nirav N. Shah, MD, assistant professor, Medical College of Wisconsin, discusses ongoing research with CAR T-cell therapy.

Nirav N. Shah, MD, assistant professor, Medical College of Wisconsin, discusses ongoing research with CAR T-cell therapy.

There are many studies evaluating future applications of CAR T cells and other cellular therapies, Shah says. There are armored CAR T cells being studied; these differ from the products currently on the market and may prove to be more effective, says Shah. In addition, ongoing research is looking at dual-targeted CAR T cells as well as sequential CAR T-cell therapy.

Moreover, some institutions are studying the role of a different type of immune effector cell called an NK cell. CAR NK is a construct that researchers hope is on the rise as another potential option for patients who have failed traditional treatments, Shah adds.

Related Videos
Shivaani Kummar, MBBS, FACP, Margaret and Lester DeArmond Endowed Chair of Cancer Research, Professor and Division Head, Division of Hematology/Medical Oncology, Oregon Health & Science University School of Medicine; co-director, Center for Experimental Therapeutics, co-deputy director, Knight Cancer Institute
Andre Goy, MD
Wenxin (Vincent) Xu, MD,
Guenther Koehne, MD, PhD
Alessandro Villa, DDS, PhD, MPH
Joseph Mikhael, MD
Michael Richardson, MD
Minesh Mehta, MD
Ruben Olivares, MD
Phillip J. Koo, MD